BEXAGLIFLOZIN vs SOTAGLIFLOZIN

Compare BEXAGLIFLOZIN (Bexagliflozin) and SOTAGLIFLOZIN (INPEFA) — clinical data, side effects, and patient experiences.

BEXAGLIFLOZIN

Bexagliflozin · SGLT-2 Inhibitor

How it works

12.1 Mechanism of Action Bexagliflozin is an inhibitor of sodium-glucose co-transporter 2 (SGLT2), the transporter responsible for reabsorption of the majority of glucose from the ...

Approved for

See full prescribing information

OralTablet

SOTAGLIFLOZIN

INPEFA · SGLT-2 Inhibitor

How it works

12.1 Mechanism of Action Sotagliflozin is an inhibitor of SGLT2 and SGLT1. Inhibiting SGLT2 reduces renal reabsorption of glucose and sodium which may influence several physiologic...

Approved for

1 INDICATIONS AND USAGE INPEFA is indicated to reduce the risk of cardiovascular death

hospitalization for heart failure

and urgent heart failure visit in adults with: heart failure or type 2 diabetes mellitus

chronic kidney disease

OralTablet

Quick Comparison

BEXAGLIFLOZINSOTAGLIFLOZIN

Drug Class

SGLT-2 Inhibitor

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

BEXAGLIFLOZIN

Weight Loss

>10%

Decreased Appetite

1-10%

Fatigue

1-10%

Headache

1-10%

Nausea

1-10%

Cough

1-10%

Shortness of Breath

1-10%

Weakness

0.1-1%

SOTAGLIFLOZIN

Dizziness

>10%

Diarrhea

>10%

Shortness of Breath

1-10%

Headache

1-10%

UTI

1-10%

Nausea

1-10%

Fatigue

0.1-1%

Vomiting

0.1-1%

FDA Warnings

BEXAGLIFLOZIN

5 WARNINGS AND PRECAUTIONS Diabetic Ketoacidosis in Patients with Type 1 Diabetes Mellitus and Other Ketoacidosis: Consider ketone monitoring in patients at risk for ketoacidosis, as indicated
1 ) Lower limb amputation: Consider factors that may increase the risk for amputations before initiating bexagliflozin tablets
4 ) Hypoglycemia: Consider a lower dose of insulin or insulin secretagogue to reduce risk of hypoglycemia when used in combination with bexagliflozin tablets ( 5
5 ) Necrotizing Fasciitis of the Perineum (Fournier’s Gangrene): Serious, life-threatening cases have occurred in both females and males treated with SGLT2 inhibitors

SOTAGLIFLOZIN

5 WARNINGS AND PRECAUTIONS Diabetic Ketoacidosis in Patients with Type 1 Diabetes Mellitus and Other Ketoacidosis: Consider ketone monitoring in patients with type 1 diabetes mellitus and consider ketone monitoring in others at risk for ketoacidosis, as indicated
1 Diabetic Ketoacidosis in Patients with Type 1 Diabetes Mellitus and Other Ketoacidosis In patients with type 1 diabetes mellitus, INPEFA significantly increases the risk of diabetic ketoacidosis, a life-threatening event, beyond the background rate
In placebo-controlled trials of patients with type 1 diabetes mellitus, the risk of ketoacidosis was markedly increased in patients who received sodium glucose cotransporter 2 (SGLT2) inhibitors compared to patients who received placebo; this risk may be greater with higher doses of INPEFA
, history of pancreatitis or pancreatic surgery) are also risk factors for ketoacidosis

Community Sentiment Analysis

Based on 1 Reddit discussions

BEXAGLIFLOZIN

100%

positive

1 threads

SOTAGLIFLOZIN

positive

0 threads

Community Discussions

1 Reddit threads analysed for BEXAGLIFLOZIN

Overall Sentiment

Slightly positive

Comparison Threads

Avg Post Score

2 upvotes

Patient Experiences (r/pharmacy, r/AskDocs & more)

Our 14 yr old cat diagnosed as diabetic. Need suggestions for food, meds

Our almost 14 yr old cat was just diagnosed with diabetes. She's 13 lbs, has been for years. Not losing weight. Drinking a bit more water in last few months. She has arthritis so she's not "kitten-active". She's been on monthly Solensia shots for about 6 months months . In the last 18 months s

r/cats201y ago

Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.

Community Discussions

No community discussions found for SOTAGLIFLOZIN yet.

BEXAGLIFLOZIN vs SOTAGLIFLOZIN: What You Should Know

Key Differences

Both BEXAGLIFLOZIN and SOTAGLIFLOZIN belong to the SGLT-2 Inhibitor class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

BEXAGLIFLOZIN carries 4 FDA warnings. SOTAGLIFLOZIN carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

BEXAGLIFLOZIN vs EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE→EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE vs SOTAGLIFLOZIN→BEXAGLIFLOZIN vs EMPAGLIFLOZIN→EMPAGLIFLOZIN vs SOTAGLIFLOZIN→

Loading comparison data...

BEXAGLIFLOZIN vs SOTAGLIFLOZIN

Compare BEXAGLIFLOZIN (Bexagliflozin) and SOTAGLIFLOZIN (INPEFA) — clinical data, side effects, and patient experiences.

BEXAGLIFLOZIN

Bexagliflozin · SGLT-2 Inhibitor

How it works

12.1 Mechanism of Action Bexagliflozin is an inhibitor of sodium-glucose co-transporter 2 (SGLT2), the transporter responsible for reabsorption of the majority of glucose from the ...

Approved for

See full prescribing information

OralTablet

SOTAGLIFLOZIN

INPEFA · SGLT-2 Inhibitor

How it works

12.1 Mechanism of Action Sotagliflozin is an inhibitor of SGLT2 and SGLT1. Inhibiting SGLT2 reduces renal reabsorption of glucose and sodium which may influence several physiologic...

Approved for

1 INDICATIONS AND USAGE INPEFA is indicated to reduce the risk of cardiovascular death

hospitalization for heart failure

and urgent heart failure visit in adults with: heart failure or type 2 diabetes mellitus

chronic kidney disease

OralTablet

Quick Comparison

BEXAGLIFLOZINSOTAGLIFLOZIN

Drug Class

SGLT-2 Inhibitor

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

BEXAGLIFLOZIN

Weight Loss

>10%

Decreased Appetite

1-10%

Fatigue

1-10%

Headache

1-10%

Nausea

1-10%

Cough

1-10%

Shortness of Breath

1-10%

Weakness

0.1-1%

SOTAGLIFLOZIN

Dizziness

>10%

Diarrhea

>10%

Shortness of Breath

1-10%

Headache

1-10%

UTI

1-10%

Nausea

1-10%

Fatigue

0.1-1%

Vomiting

0.1-1%

FDA Warnings

BEXAGLIFLOZIN

5 WARNINGS AND PRECAUTIONS Diabetic Ketoacidosis in Patients with Type 1 Diabetes Mellitus and Other Ketoacidosis: Consider ketone monitoring in patients at risk for ketoacidosis, as indicated
1 ) Lower limb amputation: Consider factors that may increase the risk for amputations before initiating bexagliflozin tablets
4 ) Hypoglycemia: Consider a lower dose of insulin or insulin secretagogue to reduce risk of hypoglycemia when used in combination with bexagliflozin tablets ( 5
5 ) Necrotizing Fasciitis of the Perineum (Fournier’s Gangrene): Serious, life-threatening cases have occurred in both females and males treated with SGLT2 inhibitors

SOTAGLIFLOZIN

5 WARNINGS AND PRECAUTIONS Diabetic Ketoacidosis in Patients with Type 1 Diabetes Mellitus and Other Ketoacidosis: Consider ketone monitoring in patients with type 1 diabetes mellitus and consider ketone monitoring in others at risk for ketoacidosis, as indicated
1 Diabetic Ketoacidosis in Patients with Type 1 Diabetes Mellitus and Other Ketoacidosis In patients with type 1 diabetes mellitus, INPEFA significantly increases the risk of diabetic ketoacidosis, a life-threatening event, beyond the background rate
In placebo-controlled trials of patients with type 1 diabetes mellitus, the risk of ketoacidosis was markedly increased in patients who received sodium glucose cotransporter 2 (SGLT2) inhibitors compared to patients who received placebo; this risk may be greater with higher doses of INPEFA
, history of pancreatitis or pancreatic surgery) are also risk factors for ketoacidosis

Community Sentiment Analysis

Based on 1 Reddit discussions

BEXAGLIFLOZIN

100%

positive

1 threads

SOTAGLIFLOZIN

positive

0 threads

Community Discussions

1 Reddit threads analysed for BEXAGLIFLOZIN

Overall Sentiment

Slightly positive

Comparison Threads

Avg Post Score

2 upvotes

Patient Experiences (r/pharmacy, r/AskDocs & more)

Our 14 yr old cat diagnosed as diabetic. Need suggestions for food, meds

r/cats201y ago

Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.

Community Discussions

No community discussions found for SOTAGLIFLOZIN yet.

BEXAGLIFLOZIN vs SOTAGLIFLOZIN: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.